BEN

Dr. BEN BAKONDI

Address 1	:
Address 2	:
Title	:	Dr.
First Name	:	BEN
Last Name	:	BAKONDI
Email ID	:	[email protected]
Country	:	United States
State	:	California
Zipcode	:	90069

Department	:	Biomedical Science
Area of Research
Retinal degeneration
Area of Expertise
Stem cells & gene editing therapies
Brief Description of Research Interest :
My research focus is to define the mechanisms by which stem cells protect tissues from disease and injury. My graduate studies addressed models of acute ischemic injury such as stroke, and in my postdoctoral training I evaluate vision rescue in models of progressive retinal disease such as age-related macular degeneration. I am also evaluating the use of CRISPR/Cas9-based genome editing approaches as in vivo therapy in models of autosomal dominant retinitis pigmentosa.
Representative Publications :
Bakondi B. In vivo versus ex vivo CRISPR therapies for retinal dystrophy. Expert Reviews of Ophthalmology. 2016 Nov;11(6):397-400. Doi:10.1080/17469899.2016.1251316 Bakondi B, Girman S, Lu B, Wang S. Multimodal Delivery of Isogenic Mesenchymal Stem Cells Yields Synergistic Protection from Retinal Degeneration and Vision Loss. Stem Cells Translational Medicine. 2017 Feb;6(2):444-457. Doi:10.5966/sctm.2016-0181 Bakondi B, Lv W, Lu B, Jones MK, Tsai Y, Kim KJ, Levy R, Akhtar AA, Breunig JJ, Svendsen CN, Wang S. In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in theS334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa. Molecular Therapy. 2016 24(3):556-563. Equal contribution. Doi:10.1038/mt.2015.220 Tsai Y, Lu B, Bakondi B, Girman S, Sahabian A, Sareen D, Svendsen CN, Wang S. Human iPSC-derived neural progenitor cells preserve vision in a preclinical model of AMD. Stem Cells. 2015 33(8);2537-2549. Doi:10.1002/stem.2032 Bakondi B, Shimada IS, Peterson BM, and Spees JL. SDF-1 secreted by CD133-derived MSCs promotes neural progenitor cell survival through CXCR7. Stem Cells & Development. 2011 Jun;20(6):1021-1029. Doi:10.1089/scd.2010.0198 Bakondi B, and Spees, JL. Human CD133-derived bone marrow stromal cells establish ectopic hematopoietic microenvironments in immunodeficient mice. Biochemical and Biophysical Research Communications. 2010 Sep;400(2):212-218. Doi:10.1016/j.bbrc.2010.08.040 Bakondi B, Shimada IS, Perry A, Munoz JR, Ylostalo J, Howard AB, Gregory CA, and Spees JL. CD133 identifies a human bone marrow stem/progenitor cell subpopulation with a repertoire of secreted factors that protect against stroke. Molecular Therapy. 2009 17:1938-1947. *Equal contribution. Doi:10.1038/mt.2009.185